Silaris™ is a unique molecular diagnostic test that offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of true laboratory‐based PCR testing for point‐of‐care (POC) infectious disease diagnosis. The system utilizes proprietary OscAR™ technology within a state-of-the art microfluidic cassette allowing facilities to implement an affordable, high performing, CLIA Waived, molecular testing option to diagnose and treat patients quickly and effectively. The platform is cleared for the detection of the influenza A and B virus, showing a sensitivity of 97% for Flu A and 94% for Flu B. For more information, visit www.silaris.com.